|
Delivering on the Promise of Germline Genetic Testing for RUNX1 Variants |
University of Washington, Seattle |
The RUNX1 Research Program |
|
Using Chemical Genetics to Define the Precise Role of RUNX1 in Transcription and Beyond |
Albert Einstein College of Medicine |
The RUNX1 Research Program |
|
Characterizing Inflammatory Phenotypes Associated with RUNX1 Deficiency |
Dana-Farber Cancer Institute |
The RUNX1 Research Program |
|
Role of PHF6 Mutations in Germline RUNX1 Deficiency Associated Hematopoietic Disorders |
Boston Children's Hospital |
The RUNX1 Research Program |
|
Assessing Clonal Fitness and Mechanisms of Clonal Evolution in FPD-MN |
Memorial Sloan-Kettering Cancer Center |
The RUNX1 Research Program |
|
Modeling familial platelet disorder associated RUNX1 mutations in mice |
University of Massachusetts Medical School |
The RUNX1 Research Program |
|
Restoring RUNX1 Levels in FPD/AML |
University of Washington, Seattle |
The RUNX1 Research Program |
|
Characterization of Pre-Leukemia Associated with Familial RUNX1 Mutations |
Stanford University |
The RUNX1 Research Program |
|
Identifying Therapeutic Targets to Prevent Progression of Familial RUNX1 Disorder to AML Using Novel iPSC Models |
Icahn School of Medicine at Mount Sinai |
The RUNX1 Research Program |
|
Pharmacologic Enhancement of Residual Wild Type RUNX1 Protein Activity in FPD/AML |
Boston Children's Hospital |
The RUNX1 Research Program |
